Jul 17, 2026 08:03AM
Jul 14, 2026 08:05AM
Jul 13, 2026 07:56AM
Jul 10, 2026 08:42AM
Jul 9, 2026 07:10AM
Jul 6, 2026 04:14PM
Jul 6, 2026 01:45PM EU approves AbbVie's Tepkinly combo for follicular lymphoma
Jul 6, 2026 06:43AM
Jul 1, 2026 08:01AM
Jun 30, 2026 06:02AM
Jun 29, 2026 04:20PM
Jun 26, 2026 04:52PM
Jun 23, 2026 09:12AM
Jun 23, 2026 08:00AM Health Canada approves AbbVie's Boey for frown line treatment
Jun 23, 2026 07:24AM
Jun 23, 2026 07:22AM
Jun 23, 2026 05:39AM
Jun 23, 2026 04:09AM
Jun 22, 2026 06:23AM
Jun 18, 2026 04:07PM
Jun 12, 2026 02:42PM Leerink highlights drug demand rebound after Memorial Day
Jun 12, 2026 03:03AM
Jun 8, 2026 08:01AM
May 29, 2026 08:00AM
May 27, 2026 03:38PM
May 22, 2026 05:31AM
May 18, 2026 10:59AM
May 14, 2026 08:25AM Abbvie (ABBV) PT Raised to $298 at Piper Sandler
May 8, 2026 12:04PM
May 5, 2026 08:05AM
Apr 30, 2026 06:59AM
Apr 30, 2026 06:11AM
Apr 30, 2026 04:25AM
Apr 29, 2026 07:48AM
Apr 29, 2026 12:00AM AbbVie Q1 earnings preview: analysts eye immunology growth trends
Apr 28, 2026 07:01AM
Apr 27, 2026 08:05AM
Apr 23, 2026 04:06PM
Apr 23, 2026 09:20AM
Apr 22, 2026 12:28PM
Apr 20, 2026 04:36PM
Apr 13, 2026 05:52AM Bernstein on US Pharma and Biotech: Who might buy whom?
Apr 10, 2026 08:36AM
Apr 10, 2026 06:57AM
Apr 8, 2026 07:31AM
Mar 30, 2026 08:01AM
Mar 26, 2026 05:45AM
Mar 18, 2026 09:21AM
Mar 12, 2026 06:55AM Guggenheim Reiterates Buy Rating on Abbvie (ABBV)
Mar 9, 2026 11:52AM

419,875 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All